In vitro and in vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections
作者： Debra C. Quenelle , Kathy A. Keith , Earl R. Kern
DOI: 10.1016/J.ANTIVIRAL.2006.02.010
关键词:
摘要: … reducing the lesion score-day-area under the curve (AUC) or mean peak lesion score-day-area of VV or CV when infections were initiated by the orofacial route. In the CV infections, a …
elsevier.com
sci-hub.se 参考文章(29)
G. Domagk, R. Behnisch, F. Mietzsch, H. S. Schmidt, Uber eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse Naturwissenschaften. ,vol. 33, pp. 315- 315 ,(1946) , 10.1007/BF00624524
D.J. Bauer, P.W. Sadler, New antiviral chemotherapeutic agent active against smallpox infection. The Lancet. ,vol. 275, pp. 1110- 1111 ,(1960) , 10.1016/S0140-6736(60)90990-9
Robert O Baker, Mike Bray, John W Huggins, Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Research. ,vol. 57, pp. 13- 23 ,(2003) , 10.1016/S0166-3542(02)00196-1
Michael C. Pirrung, Sunil V. Pansare, Koushik Das Sarma, Kathy A. Keith, Earl R. Kern, Combinatorial Optimization of Isatin-β-Thiosemicarbazones as Anti-poxvirus Agents Journal of Medicinal Chemistry. ,vol. 48, pp. 3045- 3050 ,(2005) , 10.1021/JM049147H
C. H. Nash, Effect of Carbon Dioxide on Synthesis of Erythromycin Antimicrobial Agents and Chemotherapy. ,vol. 5, pp. 544- 545 ,(1974) , 10.1128/AAC.5.5.544
D. J. Bauer, CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1‐METHYLISATIN 3‐THIOSEMICARBAZONE) * Annals of the New York Academy of Sciences. ,vol. 130, pp. 110- 117 ,(2006) , 10.1111/J.1749-6632.1965.TB12545.X
A. R. Rao, J. A. McFadzean, S. Squires, THE LABORATORY AND CLINICAL ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE (M & B 7714) AGAINST POX VIRUSES Annals of the New York Academy of Sciences. ,vol. 130, pp. 118- 127 ,(2006) , 10.1111/J.1749-6632.1965.TB12546.X
W. Turner, D. J. Bauer, R. H. Nimmo-Smith, Eczema Vaccinatum Treated with N-Methylisatin β-Thiosemicarbazone BMJ. ,vol. 1, pp. 1317- 1319 ,(1962) , 10.1136/BMJ.1.5288.1317
Donald F. Smee, Kevin W. Bailey, Min‐Hui Wong, Miles K. Wandersee, Robert W. Sidwell, Topical Cidofovir Is More Effective than Is Parenteral Therapy for Treatment of Progressive Vaccinia in Immunocompromised Mice The Journal of Infectious Diseases. ,vol. 190, pp. 1132- 1139 ,(2004) , 10.1086/422696
Erik De Clercq, Cidofovir in the treatment of poxvirus infections Antiviral Research. ,vol. 55, pp. 1- 13 ,(2002) , 10.1016/S0166-3542(02)00008-6